In re Rosuvastatin Calcium Patent Litigation

Courts have looked to whether a reissue applicant was diligent in correcting the errors in the patent, even for narrowing reissues; on the facts, the applicant was found diligent despite a multi-year delay after learning of an invalidating reference.

Generated summary for orientation only — not legal advice. Verify against the opinion.